Apnea in the newborn

Apnea, defined as cessation of breathing resulting in pathological changes in heart rate and oxygen saturation, is a common occurrence especially in preterm neonates. It is due to immaturity of the central nervous system (apnea of prematurity) or secondary to other causes such as metabolic disturbances etc. Secondary causes of apnea should be excluded before a diagnosis of apnea of prematurity is made. Methylxanthines and continuous positive airway pressure form the mainstay of treatment. Mechanical ventilation is reserved for apnea resistant to the above therapy. An approach to the management of apnea in neonates is described.

[1]  Laura A Stokowski,et al.  A primer on Apnea of prematurity. , 2005, Advances in neonatal care : official journal of the National Association of Neonatal Nurses.

[2]  P. Davis,et al.  Continuous positive airway pressure versus theophylline for apnea in preterm infants. , 2001, The Cochrane database of systematic reviews.

[3]  D. Henderson-smart,et al.  Doxapram versus methylxanthine for apnea in preterm infants. , 2000, The Cochrane database of systematic reviews.

[4]  D. Henderson-smart,et al.  Prophylactic methylxanthine for prevention of apnoea in preterm infants. , 2010, The Cochrane database of systematic reviews.

[5]  P. Davis,et al.  Prophylactic methylxanthines for extubation in preterm infants. , 2003, The Cochrane database of systematic reviews.

[6]  C. Perry,et al.  Caffeine Citrate , 2020, Reactions Weekly.

[7]  D. Henderson-smart,et al.  Doxapram treatment for apnea in preterm infants. , 2004, The Cochrane database of systematic reviews.

[8]  Clinical Associations, Treatment, and Outcome of Apnea of Prematurity , 2002 .

[9]  P. Davis,et al.  Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in preterm infants , 2003 .

[10]  David J Henderson-Smart,et al.  Methylxanthine treatment for apnoea in preterm infants. , 2010, The Cochrane database of systematic reviews.

[11]  D. Henderson-smart,et al.  Kinesthetic stimulation for preventing apnea in preterm infants. , 2002, The Cochrane database of systematic reviews.

[12]  D. Henderson-smart,et al.  Caffeine versus theophylline for apnea in preterm infants. , 2010, The Cochrane database of systematic reviews.

[13]  J Bhatia,et al.  Current Options in the Management of Apnea of Prematurity , 2000, Clinical pediatrics.

[14]  D. Jardine,et al.  Relationship of benzyl alcohol to kernicterus, intraventricular hemorrhage, and mortality in preterm infants. , 1989, Pediatrics.

[15]  D. Henderson-smart,et al.  Prophylactic methylxanthine for preventing of apnea in preterm infants. , 2000, The Cochrane database of systematic reviews.

[16]  D. Henderson-smart,et al.  Kinesthetic stimulation for treating apnea in preterm infants. , 1999, The Cochrane database of systematic reviews.

[17]  Richard J Martin,et al.  Pathophysiologic Mechanisms Underlying Apnea of Prematurity , 2002 .